Sleep Disorders Trial, Recruiting NCT05735444 Sponsor: Shanghai Jiao Tong University School of Medicine Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT05735444
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who agree to take part and sign a consent form
  • People who are at least 18 years old
  • People who score 3 or more points on a screening tool called the STOP-Bang questionnaire, which checks for signs of sleep apnoea
  • People who have completed an overnight sleep study in a hospital (called polysomnography)
  • People who are currently using a CPAP machine (a breathing device used during sleep)

Who may not be able to join:

  • People whose blood pressure reading is very high (clinic systolic/diastolic blood pressure at or above 180/110 mmHg)
  • People who have been treated or are currently being treated for sleep apnoea using a method other than CPAP
  • People with serious lung conditions such as chronic obstructive pulmonary disease (COPD), or conditions that make CPAP unsafe, such as a collapsed lung, air-filled lung cysts, or a recent stroke
  • People who have other sleep disorders or insomnia
  • People who are unable to tolerate using a CPAP machine
  • People who have difficulty with thinking or understanding that prevents them from being able to sign a consent form
  • People who the trial doctor considers unsuitable for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jiguang Wang, MD, PhD, Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Phone: +86-21-64370045

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai Jiao Tong University School of Medicine
Registry
ClinicalTrials.gov
Start date
1 January 2023
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in mean 24-hour ambulatory blood pressure after 12-month CPAP treatment from baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov